Article
test
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Nxera and Cancer Research UK Advance Oral EP4 Antagonist into Phase IIa Study
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
CSL Backs Late-Stage Development of VarmX’s Coagulation Therapy VMX-C001X
Mastering Antibody-Drug Conjugates
Limula’s LimONE System Targets Consistency in Stem Cell Transplants
Gyala Therapeutics’ CAR-T Leukemia Therapy Shows Promise, Heads for Clinical Trial